Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Ultragenyx Pharmaceutical (RARE)

NASDAQ:RARE

US Market

RARE

Ultragenyx Pharmaceutical

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Ultragenyx Pharmaceutical (RARE) Stock News & Sentiment

968 Followers

Ultragenyx’s Strategic Progress with DTX401 Gene Therapy Drives Buy Rating Amid Promising Market Potential

Ratings

Ultragenyx’s Strategic Progress with DTX401 Gene Therapy Drives Buy Rating Amid Promising Market Potential

9d ago

Ultragenyx Pharmaceutical: Promising Developments and Strategic Advancements Support Buy Rating

Ratings

Ultragenyx Pharmaceutical: Promising Developments and Strategic Advancements Support Buy Rating

10d ago

Ultragenyx Begins FDA Application for DTX401 Gene Therapy

Company Announcements

Ultragenyx Begins FDA Application for DTX401 Gene Therapy

10d ago

Ultragenyx Pharmaceutical’s Setrusumab: A Promising Buy with Potential for Significant Fracture Reduction in Osteogenesis Imperfecta

Ratings

Ultragenyx Pharmaceutical’s Setrusumab: A Promising Buy with Potential for Significant Fracture Reduction in Osteogenesis Imperfecta

17d ago

Ultragenyx Pharmaceutical’s Promising Growth and Financial Outlook: Analyst Recommends Buy

Ratings

Ultragenyx Pharmaceutical’s Promising Growth and Financial Outlook: Analyst Recommends Buy

22d ago

Ultragenyx Earnings Call: Clinical Wins Amid Financial Challenges

Company Announcements

Ultragenyx Earnings Call: Clinical Wins Amid Financial Challenges

22d ago

Ultragenyx Pharmaceutical: Strong Q2 Results and Promising Future Justify Buy Rating

Ratings

Ultragenyx Pharmaceutical: Strong Q2 Results and Promising Future Justify Buy Rating

22d ago

More RARE News >

RARE News on the Web

2025-08-06

Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y

Zacks

Neutral

2025-08-06

Why Ultragenyx Pharmaceutical Inc.’s (RARE) Stock Is Down 5.72%

AAII

Neutral

2025-08-05

Ultragenyx (RARE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

Neutral

2025-07-31

Earnings Preview: Verastem (VSTM) Q2 Earnings Expected to Decline

Zacks

Neutral

2025-07-28

Piper Sandler Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TipRanks News

Neutral

2025-07-24

BioHarvest Sciences Inc. (BHST) Surges 5.6%: Is This an Indication of Further Gains?

Zacks

Neutral

2025-07-23

Why Ultragenyx Pharmaceutical Inc.’s (RARE) Stock Is Up 6.01%

AAII

Neutral

2025-07-15

Ultragenyx Pharmaceuticals Gets CRL for UX111 Gene Therapy for MPS IIIA

Zacks

Neutral

News Score - Last 7 Days

Neutral

RARE

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week50%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RARE’s Media Buzz Sentiment?

Currently, no data Available

What is RARE’s weekly average amount of articles?

Currently, no data Available

What is RARE’s News Sentiment?

50% of articles about RARE were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

COOCooper Co

ANSLFAnsell

WBAWalgreens Boots Alliance

S5YASigma Healthcare Ltd

RMSYFRamsay Health Care

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing